Jared M Emery

Title: The Innovative Contributions of Jared M Emery

Introduction

Jared M Emery is a notable inventor based in Houston, TX (US), recognized for his significant contributions to the field of ophthalmology. With a total of 4 patents to his name, Emery has focused on developing innovative solutions to improve eye health and surgical outcomes.

Latest Patents

Emery's latest patents include groundbreaking work on monoclonal antibodies against lens epithelial cells. This invention provides compositions and methods for preventing the proliferation of remnant lens epithelial cells following extracapsular extraction. The method involves introducing complement-fixing monoclonal antibodies specific for lens epithelial cells into the anterior chamber of the eye. This process effectively lyses the remnant lens epithelial cells, which can be utilized during or after cataract extraction procedures. Another significant patent involves mitotic inhibitors that prevent posterior lens capsule opacification. These inhibitors consist of osmotically balanced solutions containing methotrexate or retinoic acid, which are instilled in the anterior chamber immediately after lens removal.

Career Highlights

Throughout his career, Jared M Emery has worked with esteemed institutions such as Baylor College of Medicine and Houston Biotechnology Incorporated. His work has contributed to advancements in cataract surgery and the management of lens-related complications.

Collaborations

Emery has collaborated with notable professionals in his field, including Dominic M Lam and Raymond Y Chan. These partnerships have further enhanced the impact of his research and innovations.

Conclusion

Jared M Emery's contributions to ophthalmology through his patents and collaborations highlight his commitment to improving eye health. His innovative approaches continue to influence the field and provide valuable solutions for patients undergoing cataract surgery.